| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.1M | -22.5% | — |
| R&D Expense | $97.8M | -10.0% | +11.4% |
| SG&A Expense | $19.5M | -43.3% | +84.6% |
| Operating Income | -$115.3M | +18.0% | -17.2% |
| Pre-tax Income | -$110.8M | -318.2% | -18.9% |
| Income Tax | $0 | +100.0% | — |
| Net Income | -$110.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $65.3M | -57.0% | -69.4% |
| Short-term Investments | $312.5M | -6.6% | +110.5% |
| Current Assets | $393.3M | -24.0% | +4.2% |
| Total Assets | $488.0M | -20.1% | +18.3% |
| Current Liabilities | $65.4M | -23.6% | +95.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$297.6M | — | — |
| Capital Expenditures | $653K | — | — |
| Investing Cash Flow | $192.9M | — | — |
| Financing Cash Flow | $749K | — | — |
| Free Cash Flow | -$298.3M | — | — |
| -18.9% |
| EPS (Basic) | -$1.06 | -235.9% | +38.7% |
| EPS (Diluted) | -$1.06 | -237.7% | +38.7% |
| $103.2M |
| -17.8% |
| +60.9% |
| Stockholders' Equity | $384.8M | -20.7% | +10.4% |